Dr. Ian Fearon has over 30 years of scientific and regulatory experience, specializing in biological and psychological effects of nicotine, and clinical/behavioural studies to assess health impacts of electronic cigarettes. Ian’s career has included roles as Senior Director Clinical and Regulatory Affairs EMEA at JUUL Labs, Director of Research at Celerion Inc, and Principal Scientist and Head of Clinical Research at British American Tobacco (BAT). Ian is a highly cited scientific researcher and writer, contributing to more than 60 peer-reviewed papers and book chapters and generating over 2,700 citations.